New drugs and clinical trials in diabetes and hypertension.
Hypertension is a well-established risk factor for cerebro-cardiovascular disease in diabetics, as well as for progressing renal disease. Several pathophysiological mechanisms link hypertension with non-insulin-dependent diabetes (NIDDM), e.g. insulin resistance. This will be discussed below as regards pathophysiology and treatment possibilities, especially with new drugs in ongoing clinical trials.
Nilsson
P
P
Department of Community Health Sciences, University of Lund, Sweden.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D009765:Obesity
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents